Phuc F. Tan-Nguyen

Montreal, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

Phase I/II Trial of Durvalumab plus Tremelimumab and Stereotactic Body Radiotherapy for Metastatic Head and Neck Carcinoma.

Phase I/II Trial of Durvalumab plus Tremelimumab and Stereotactic Body Radiotherapy for Metastatic Head and Neck Carcinoma.

Journal: International journal of radiation oncology, biology, physics

Published: February 10, 2026

Treatment Interruption and Outcomes in Head and Neck Cancer: A Secondary Analysis of 3 Randomized Clinical Trials.

Treatment Interruption and Outcomes in Head and Neck Cancer: A Secondary Analysis of 3 Randomized Clinical Trials.

Journal: JAMA otolaryngology-- head & neck surgery

Published: December 04, 2025

Genome-wide association study of never-smoking non-drinking young adults developing oral squamous cell carcinoma.

Genome-wide association study of never-smoking non-drinking young adults developing oral squamous cell carcinoma.

Journal: BMC cancer

Published: November 12, 2025

A Proposal for HPV-Associated Oropharyngeal Carcinoma in the Ninth Edition Clinical TNM Classification.

A Proposal for HPV-Associated Oropharyngeal Carcinoma in the Ninth Edition Clinical TNM Classification.

Journal: JAMA otolaryngology-- head & neck surgery

Published: May 08, 2025

Impacts of a Group-Based Intervention To Mitigate Concurrent Chemotherapy and Radiotherapy-Induced Dysphagia: A Retrospective Cohort Study.

Impacts of a Group-Based Intervention To Mitigate Concurrent Chemotherapy and Radiotherapy-Induced Dysphagia: A Retrospective Cohort Study.

Journal: Dysphagia

Published: May 07, 2025

Development and Validation of a Rapid Screening Measure for Mask Anxiety in Head and Neck Cancer Patients Undergoing Radiotherapy.

Development and Validation of a Rapid Screening Measure for Mask Anxiety in Head and Neck Cancer Patients Undergoing Radiotherapy.

Journal: Psycho-oncology

Published: January 29, 2025

Postoperative Radiotherapy ± Cetuximab for Intermediate-Risk Head and Neck Cancer.

Postoperative Radiotherapy ± Cetuximab for Intermediate-Risk Head and Neck Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 22, 2025

Long-Term Feeding Tube Use in Head and Neck Cancer Survivors-An Analysis of Patient- and Treatment-Related Factors.

Long-Term Feeding Tube Use in Head and Neck Cancer Survivors-An Analysis of Patient- and Treatment-Related Factors.

Journal: International journal of radiation oncology, biology, physics

Published: November 12, 2024

Surrogate endpoints in clinical trials of p16-positive squamous cell carcinoma of the oropharynx: an individual patient data meta-analysis.

Surrogate endpoints in clinical trials of p16-positive squamous cell carcinoma of the oropharynx: an individual patient data meta-analysis.

Journal: The Lancet. Oncology

Published: September 09, 2023

Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinoma.

Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinoma.

Journal: Oral oncology

Published: June 24, 2023

Magnetic Resonance-Guided Radiation Therapy for Head and Neck Cancers.

Magnetic Resonance-Guided Radiation Therapy for Head and Neck Cancers.

Journal: Current oncology (Toronto, Ont.)

Published: October 02, 2022

Long-Term Update of NRG/RTOG 0522: A Randomized Phase 3 Trial of Concurrent Radiation and Cisplatin With or Without Cetuximab in Locoregionally Advanced Head and Neck Cancer.

Long-Term Update of NRG/RTOG 0522: A Randomized Phase 3 Trial of Concurrent Radiation and Cisplatin With or Without Cetuximab in Locoregionally Advanced Head and Neck Cancer.

Journal: International journal of radiation oncology, biology, physics

Published: July 06, 2022

Showing 1-12 of 57

Last Updated: 09/26/2026